SBI Arbitrage Opportunities Fund - Direct Plan - Gr vs TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
SBI Arbitrage Opportunities Fund - Direct Plan - Gr
SBI Mutual Fund
★★★★★
Equity · Sectoral
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option
Tata Mutual Fund
★★★★★
Equity · Sectoral
| Metric | SBI Arbitrage Opportun... | TATA India Pharma & He... |
|---|---|---|
| NAV | ₹586.33 | ₹37.99 |
| Star Rating | ★★★★★ | ★★ |
| Expense Ratio | 1.01% | 1.09% |
| AUM | ₹5,796 Cr | ₹1,565 Cr |
| 1M Return | -3.31% | -3.85% |
| 3M Return | +2.9% | -2.14% |
| 6M Return | +22.35% | +15.18% |
| 1Y Return | +21.62% | +6.95% |
| 3Y CAGR | +22.91% | +18.83% |
| 5Y CAGR | +17.95% | +14.16% |
| Risk Level | — | — |
| Fund Manager | Tanmaya Desai | Rupesh Patel, Sonam Udasi |